pocketful logo
undefined logo

NSE: undefined BSE: undefined

-

(-%)

Fri, 01 May 2026, 11:07 pm

Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    38.85

  • Net Profit

    7.52

  • P/B

    0.62

  • Sector P/E

    69.24

  • P/E

    17.25

  • EV/EBITDA

    29.36

  • Debt/Equity (Industry)

    1.19

  • Interest Cover (Industry)

    2.83

  • ROCE (Industry)

    14.11

  • RONW (Industry)

    14.66

  • ROE

    5.69

  • ROCE

    4.20

  • Debt/Equity

    0.80

  • EPS (TTM)

    0.07

  • Dividend Yield

    0

  • Book Value

    1.02

  • Interest Cover

    0

Analysis

all

thumbs up icon

Pros

  • Earum Pharmaceuticals is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Earum Pharmaceuticals is profitable, therefore cash runway is not a concern.
  • Earum Pharmaceuticals is profitable, therefore cash runway is not a concern.
  • Debt is covered by short term assets, assets are 3.4x debt.
  • Earum Pharmaceuticals's cash and other short term assets cover its long term commitments.
thumbs up icon

Cons

  • Unable to evaluate Earum Pharmaceuticals's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Earum Pharmaceuticals's dividend against the top 25% market benchmark as the company has not reported any payouts.
  • Operating cash flow is negative therefore debt is not well covered.
  • Interest payments on debt are not well covered by earnings (EBIT is 2.8x annual interest expense, ideally 3x coverage).
  • Earum Pharmaceuticals's level of debt (60.6%) compared to net worth is high (greater than 40%).

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersSEPT 2025JUN 2025MAR 2025DEC 2024SEPT 2024
Promoters00000
FII00000
DII00000
Public100100100100100
Government00000

Read More

Technical Analysis

RSI

37.77

MACD

-0.01

50 DMA

0.22

200 DMA

0.44

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic0.370.300.260.230.190.160.09
Fibonacci0.300.270.260.230.200.190.16
Camarilla0.240.230.230.230.210.210.20

Pivots Level: Classic

R3

+0.14

0.37

R2

+0.07

0.30

R1

+0.03

0.26

0.23
0.23
Pivot Point
LTP: 0.19

S1

-0.04

0.19

S2

-0.07

0.16

S3

-0.14

0.09

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    0.19

  • 20-EMA

    0.20

  • 30-EMA

    0.21

  • 50-EMA

    0.22

  • 100-EMA

    0.28

  • 200-EMA

    0.39

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
15 Sept 2025agm
25 Jul 2025bonus1:10 Bonus Issue of Equity Shares07 Aug 2025
07 Jul 2025bonusBonus issue 1:1007 Aug 2025
11 May 2025splitStock Split From Rs.2 to Rs.111 Jun 2025
19 Dec 2024egm
13 Dec 2024rights1:3 Rights Issue of Equity Shares19 Dec 2024
19 Nov 2024rightsRight Issue of Equity Shares19 Dec 2024
19 Sept 2024agm
29 Mar 2024egm
16 Aug 2023agm

Read More

Peer Comparison

Murae Organisor Ltd logo

Murae Organisor Ltd

Aegis Logistics Ltd logo

Aegis Logistics Ltd

Honasa Consumer Ltd logo

Honasa Consumer Ltd

Redington Ltd logo

Redington Ltd

Adani Enterprises Ltd logo

Adani Enterprises Ltd

Premier Energies Ltd logo

Premier Energies Ltd

Read More

About

Murae Organisor is mainly engaged in Pharmaceutical Business trading of pharma products and commission agent in pharma products etc.

Industry

Trading

Founded

2012

Headquarters

CEO

NITINKUMAR ASHOKKUMAR TOMAR

Employees

Contact

Website icon

Website

https://muraeglobal.com

Email icon

Email

Phone icon

Phone

91-79-48402525

Location icon

Location

G1 Ground Floor VR Complex, Nr Sanathal Cross Rd SP RingRd, Ahmedabad, Gujarat, 382210

Read More

Company History

YearHistory
No Result Found

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
TRANSGLOBAL SECURITIES LTD.Buy103063210.2704 Feb 2026
TRANSGLOBAL SECURITIES LTD.Sell93963240.2704 Feb 2026
SHARE INDIA SECURITIES LIMITEDSell80000150.2202 Feb 2026
SHARE INDIA SECURITIES LIMITEDBuy103165760.2302 Feb 2026
TRANSGLOBAL SECURITIES LTD.Buy75000000.2302 Feb 2026
TRANSGLOBAL SECURITIES LTD.Sell105000010.2302 Feb 2026
HARPREET SINGH GREWALSell146843050.2703 Nov 2025
HARPREET SINGH GREWALBuy146843050.2703 Nov 2025
EKLINGJI TRADELINK PRIVATE LIMITEDSell196023900.2830 Oct 2025
EKLINGJI TRADELINK PRIVATE LIMITEDSell209116360.2929 Oct 2025

Read More

News

MURAE Organisor Ltd Evaluates Strategic Agro-Sector Investments Following Proposed ₹80 Crore QIP

MURAE Organisor Ltd is evaluating strategic investments in agro-sector infrastructure and research development following a proposed Qualified Institutional Placement (QIP) of up to ₹80 Crores. The company plans to establish an agro research lab, develop integrated processing facilities, implement digital traceability systems, and enhance quality testing capabilities for exports. The indicative budget allocation includes ₹25-30 crores for agro processing infrastructure, ₹30-35 crores for working capital, ₹5-7 crores for research lab setup, ₹5-8 crores for digital systems, and ₹3-5 crores for contingency. The company emphasized these are preliminary internal planning documents with no firm commitments made. Final deployment plans will be presented to the Board after QIP completion, subject to shareholder and regulatory approvals.

28 Aug 2025

stock

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800